Ng et al. [12] conservatively estimated that a 6.7 kb MLL cleavage fragment was detected in the bone marrow 3 months after a low dose of etoposide and 3 months prior to the diagnosis of overt t-AML. The gene discussed is KMT2A; the disease is acute myeloid leukemia.